Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TSLL vs MRNA✓SelectedUSD · MRNATSLL vs MRNA performance historyLatest closeAs of+0.10%11/17
Stock and ETF performance explorer

TSLL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-17.2%
MRNA return
+168.0%
Excess return
-185.3%
Maximum drawdown
-82.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.1%-3.9%+4.0%+0.6%
7D-0.4%-17.6%+17.1%+2.0%
30D+10.1%-5.1%+15.2%+10.8%
3M+14.7%+220.8%-206.1%-9.4%
6M-33.9%+321.7%-355.6%-52.8%
YTD-47.5%+601.3%-648.8%-68.5%
1Y-38.6%+735.2%-773.8%-65.5%
3Y-17.2%+170.5%-187.8%-43.9%
All-17.2%+168.0%-185.3%-43.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling